Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. TSLA
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
(NASDAQ: ZYME) Delayed: 23.97 +0.71 (3.05%)
Previous Close $23.26    52 Week High $ 
Open $22.90    52 Week Low $ 
Day High $24.05    P/E N/A 
Day Low $22.90    EPS $ 
Volume 247,755